Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients

Figure 9

Validation of the hub genes of ARS. (a) CDKN2A. (b) E2F1. (c) ENDOG. (d) EZH2. (e) HMGA1. (f) PLK1. (g) SLC2A1.

(a)

(b)

(c)

(d)

(e)

(f)

(g)